Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1321-1330 of 1,433) with videos related to

Pageof 144
Sort By:
Cancers|April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus ReviewMattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
The Journal of Biological Chemistry|January 29, 2020
A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD<sup>+</sup> salvage pathway in the nucleusAmbra A Grolla, Riccardo Miggiano, Daniele Di Marino, et al.
JCO Precision Oncology|September 10, 2025
Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?Riziero Esposito Abate, Alessandro Morabito, Michele Milella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
Dermatologic Therapy|February 23, 2021
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczemaSilvia Ferrucci, Paola Persichini, Massimo Gola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2026
EUS-guided drainage of Post-Surgical versus Post-Pancreatitis collections (the RESPELL study): A prospective comparison of clinical presentations and therapeutic outcomesGiuseppe Vanella, Francesco Frigo, Roberto Leone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancerR Dent, F André, A Gonçalves, et al.
Human Fertility (Cambridge, England)|March 8, 2022
The paradox of the Italian clinical embryologist in the national public health system: hints towards harmonization of a postgraduate educational curriculumAlessandra Alteri, Liana Bosco, Sandrine Chamayou, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Journal of the American Academy of Dermatology|January 21, 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patientsAngelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, et al.
Pageof 144

Showing results (1321-1330 of 1,433) with videos related to

Sort By:
Pageof 144
Cancers|April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus ReviewMattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
The Journal of Biological Chemistry|January 29, 2020
A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD<sup>+</sup> salvage pathway in the nucleusAmbra A Grolla, Riccardo Miggiano, Daniele Di Marino, et al.
JCO Precision Oncology|September 10, 2025
Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?Riziero Esposito Abate, Alessandro Morabito, Michele Milella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
Dermatologic Therapy|February 23, 2021
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczemaSilvia Ferrucci, Paola Persichini, Massimo Gola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2026
EUS-guided drainage of Post-Surgical versus Post-Pancreatitis collections (the RESPELL study): A prospective comparison of clinical presentations and therapeutic outcomesGiuseppe Vanella, Francesco Frigo, Roberto Leone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancerR Dent, F André, A Gonçalves, et al.
Human Fertility (Cambridge, England)|March 8, 2022
The paradox of the Italian clinical embryologist in the national public health system: hints towards harmonization of a postgraduate educational curriculumAlessandra Alteri, Liana Bosco, Sandrine Chamayou, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Journal of the American Academy of Dermatology|January 21, 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patientsAngelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, et al.
Pageof 144